INS and obesity disorder: By contrast, supplementation with indomethacin reduced obesity development and improved insulin sensitivity in obesity prone HFD-fed C57BL/6J mice8, clearly pointing to mouse strain dependent differences in the responses to inhibition of cyclooxygenase activity.